Regional Venous Drainage of the Human Heart*
... ventricular myocardium. It is believed by many investigators that coronary sinus blood in man is composed almost entirely of left ventricular efflux. That this is true in the canine heart is firmly established (Rayford et al., 1959). This principle has been widely accepted in the many studies which ...
... ventricular myocardium. It is believed by many investigators that coronary sinus blood in man is composed almost entirely of left ventricular efflux. That this is true in the canine heart is firmly established (Rayford et al., 1959). This principle has been widely accepted in the many studies which ...
Commenatry case
... • Our patient underwent venous phase CT angiography, which revealed occlusion of the left superior pulmonary vein and high-grade stenosis of the left inferior pulmonary vein and both right pulmonary veins. ...
... • Our patient underwent venous phase CT angiography, which revealed occlusion of the left superior pulmonary vein and high-grade stenosis of the left inferior pulmonary vein and both right pulmonary veins. ...
differential diagnosis of coronary pains in chest. particularity of the
... stairs), and by other factors that increase myocardial oxygen demand: emotional stress, stress, high blood pressure, an increase in venous flow to the heart, heart failure ( left ventricular volume overload), tachycardia, any origin, etc. The first clinical manifestation of coronary heart disease ca ...
... stairs), and by other factors that increase myocardial oxygen demand: emotional stress, stress, high blood pressure, an increase in venous flow to the heart, heart failure ( left ventricular volume overload), tachycardia, any origin, etc. The first clinical manifestation of coronary heart disease ca ...
The rationale of using calcium antagonists in the treatment of
... Mechanisms of action and indications for Ca-antagonists in patients with coronary heart disease The detailed mode of action of various subtypes of Caantagonists will not be discussed in this context, but can be found in the references [eg, 1, 20, 34, 35]. In brief: 1. In principle, Ca-antagonists ac ...
... Mechanisms of action and indications for Ca-antagonists in patients with coronary heart disease The detailed mode of action of various subtypes of Caantagonists will not be discussed in this context, but can be found in the references [eg, 1, 20, 34, 35]. In brief: 1. In principle, Ca-antagonists ac ...
Relationship between Myocardial Performance Index and Severity
... since been studied in several other cardiac disorders including heart failure, myocardial infarction (MI), systemic hypertension (HT) and diabetes mellitus (DM) and found to predict both worsened morbidity and mortality [6,7]. Although alteration of MPI in patients with MI is well known, there were ...
... since been studied in several other cardiac disorders including heart failure, myocardial infarction (MI), systemic hypertension (HT) and diabetes mellitus (DM) and found to predict both worsened morbidity and mortality [6,7]. Although alteration of MPI in patients with MI is well known, there were ...
differential diagnosis of coronary pains in chest. particularity of the
... stairs), and by other factors that increase myocardial oxygen demand: emotional stress, stress, high blood pressure, an increase in venous flow to the heart, heart failure ( left ventricular volume overload), tachycardia, any origin, etc. The first clinical manifestation of coronary heart disease ca ...
... stairs), and by other factors that increase myocardial oxygen demand: emotional stress, stress, high blood pressure, an increase in venous flow to the heart, heart failure ( left ventricular volume overload), tachycardia, any origin, etc. The first clinical manifestation of coronary heart disease ca ...
Prediction of long−term outcome after primary
... with a first anterior STEMI treated with primary PCI in a single 24-hours PCI referral centre examined the long-term prognostic relevance of different demographic, clinical, ECG, echocardiographic and angiographic variables. Accurate risk stratification after primary PCI is of importance in guiding ...
... with a first anterior STEMI treated with primary PCI in a single 24-hours PCI referral centre examined the long-term prognostic relevance of different demographic, clinical, ECG, echocardiographic and angiographic variables. Accurate risk stratification after primary PCI is of importance in guiding ...
Effect of Cardiac Rehabilitation on Cardiovascular Events after
... According to the ACSM risk stratification guidelines, patients in classes A and B were recommended to attend at least 6 CR sessions. The mean number of CR sessions was 13.3 ± 12.9 in the CRG. Patients who participated in CR had a significantly higher 6-year event-free rate than that of patients who ...
... According to the ACSM risk stratification guidelines, patients in classes A and B were recommended to attend at least 6 CR sessions. The mean number of CR sessions was 13.3 ± 12.9 in the CRG. Patients who participated in CR had a significantly higher 6-year event-free rate than that of patients who ...
Coronary Physiology
... NO is a crucial signaling molecule in vascular biology Produced in endothelial cells Indirectly catalyzes intracellular cGMP formation from GTP cGMP acts a secondary messenger, ultimately causing the relaxation of endothelial smooth muscle by decreasing intracellular Ca2+ concentration and a decrea ...
... NO is a crucial signaling molecule in vascular biology Produced in endothelial cells Indirectly catalyzes intracellular cGMP formation from GTP cGMP acts a secondary messenger, ultimately causing the relaxation of endothelial smooth muscle by decreasing intracellular Ca2+ concentration and a decrea ...
angina
... 3. Patients with careers that involve the safety of others (e.g., airline pilots) who have questionable symptoms, suspicious or positive noninvasive tests. 4. Patients with aortic stenosis or hypertrophic cardiomyopathy and angina in whom the pain could be due to CAD. 5. Male patients aged 45 and fe ...
... 3. Patients with careers that involve the safety of others (e.g., airline pilots) who have questionable symptoms, suspicious or positive noninvasive tests. 4. Patients with aortic stenosis or hypertrophic cardiomyopathy and angina in whom the pain could be due to CAD. 5. Male patients aged 45 and fe ...
Summary
... resistance in patients. In chapter 5 two indices were studied to assess microvascular resistance (MR) in coronary arteries with a stenosis. Special attention was given to coronary arteries with a severe stenosis, where conflicting results on MR values have been reported. The first index used was the ...
... resistance in patients. In chapter 5 two indices were studied to assess microvascular resistance (MR) in coronary arteries with a stenosis. Special attention was given to coronary arteries with a severe stenosis, where conflicting results on MR values have been reported. The first index used was the ...
Slajd 1 - Zakład Farmakologii Klinicznej w Poznaniu
... The most important ADRs are liver toxicity (↑ ATs) and myopathy ( pain, weakness, ↑CK ≥ 10 X) Rhabdomyolysis and acute renal failure – very rare Risk of muscle toxicity increases during therapy with cyclosporine, erythromycin, clarithromycin, azole antifungals, protease inhibitors – CYP 3A4 inhibito ...
... The most important ADRs are liver toxicity (↑ ATs) and myopathy ( pain, weakness, ↑CK ≥ 10 X) Rhabdomyolysis and acute renal failure – very rare Risk of muscle toxicity increases during therapy with cyclosporine, erythromycin, clarithromycin, azole antifungals, protease inhibitors – CYP 3A4 inhibito ...
acute coronary syndrome - The Professional Medical Journal
... been reported that cardiac disease puts around 17 million people to death each year, of which half of the deaths are caused due to acute coronary syndrome (ACS).3 The characterization of ACS is mainly done by chest pain, therefore chest pain is known to be the primary source of ACS.5 Researchers rep ...
... been reported that cardiac disease puts around 17 million people to death each year, of which half of the deaths are caused due to acute coronary syndrome (ACS).3 The characterization of ACS is mainly done by chest pain, therefore chest pain is known to be the primary source of ACS.5 Researchers rep ...
Case Report Right Coronary Artery Originated from the Left Anterior
... Anomalous origin of RCA from LAD has rarely been reported in the literature. We are able to find only 37 published cases with this specific coronary anomaly [8, 9]. Most of the these reported cases have been in structurally normal hearts, and there are only two cases in association with Tetralogy of ...
... Anomalous origin of RCA from LAD has rarely been reported in the literature. We are able to find only 37 published cases with this specific coronary anomaly [8, 9]. Most of the these reported cases have been in structurally normal hearts, and there are only two cases in association with Tetralogy of ...
PLATO Trial - Delfini.org
... -Threat: Patients in the two arms may have received different LDs. Patients in the clopidogrel arm who received open-labeled clopidogrel LD did not received LD doses of clopidogrel again. However, patients in the ticagrelor arm who received open-labeled clopidogrel may have also received LD of ticag ...
... -Threat: Patients in the two arms may have received different LDs. Patients in the clopidogrel arm who received open-labeled clopidogrel LD did not received LD doses of clopidogrel again. However, patients in the ticagrelor arm who received open-labeled clopidogrel may have also received LD of ticag ...
Word 2MB - Australian Commission on Safety and Quality in Health
... 1990s but the average length of stay in hospital has decreased. While most hospital stays are for three days or more, stays of one day or less are more frequent in all age groups than they were in the late 1990s, due in part to advances in medical procedures.8 Nonetheless, one-third of patients admi ...
... 1990s but the average length of stay in hospital has decreased. While most hospital stays are for three days or more, stays of one day or less are more frequent in all age groups than they were in the late 1990s, due in part to advances in medical procedures.8 Nonetheless, one-third of patients admi ...
assets.baptistonline.org
... Definitions of Statin Intensity • High: atorvastatin 40 - 80 mg/day, rosuvastatin 20 40 mg/day; • Moderate: atorvastatin 10 - 20 mg/day, rosuvastatin 5 - 10 mg/day, simvastatin 20 - 40 mg/day, pravastatin 40 mg/day, lovastatin 40 mg/day, fluvastatin XL 80 mg/day, or pitavastatin 2 - 4 mg/day; • Low ...
... Definitions of Statin Intensity • High: atorvastatin 40 - 80 mg/day, rosuvastatin 20 40 mg/day; • Moderate: atorvastatin 10 - 20 mg/day, rosuvastatin 5 - 10 mg/day, simvastatin 20 - 40 mg/day, pravastatin 40 mg/day, lovastatin 40 mg/day, fluvastatin XL 80 mg/day, or pitavastatin 2 - 4 mg/day; • Low ...
Use of indicative and reciprocal electrocardiographic changes to
... changes to help localize the site of coronary occlusion D. LUKE GLANCY, MD, AND WALEED DOGHMI, MD ...
... changes to help localize the site of coronary occlusion D. LUKE GLANCY, MD, AND WALEED DOGHMI, MD ...
New Noninvasive Diagnosis of Myocardial Ischemia of the Left
... and B were compared by the unpaired t-test. p ＜ 0.05 was considered significant. The sensitivity, specificity, positive predictive value and negative predictive value of CFR were calculated in the conventional way, as a predictor of abnormal perfusion on the 201 Tl SPECT image. Interobserver and int ...
... and B were compared by the unpaired t-test. p ＜ 0.05 was considered significant. The sensitivity, specificity, positive predictive value and negative predictive value of CFR were calculated in the conventional way, as a predictor of abnormal perfusion on the 201 Tl SPECT image. Interobserver and int ...
Common Defects With Expected Adult Survival: Acyanotic : Bicuspid
... Survival Patterns After Cath. Intervention (C) Or Surgery (S) C – stenosis Pulmonic – Valves (Dysplastic valves) C/S Pulmonic insufficiency (C/S) -> or homograft Aortic stenosis – C/S -> or C/S Discr. Subaortic – Stenosis – (S) Supravalvar aortic stenosis – (S) -> - or S Aortic insufficiency -> (S) ...
... Survival Patterns After Cath. Intervention (C) Or Surgery (S) C – stenosis Pulmonic – Valves (Dysplastic valves) C/S Pulmonic insufficiency (C/S) -> or homograft Aortic stenosis – C/S -> or C/S Discr. Subaortic – Stenosis – (S) Supravalvar aortic stenosis – (S) -> - or S Aortic insufficiency -> (S) ...
Aortic Dissection Involving the Ostium of Left Main Coronary Artery
... Type A AAD is a true surgical emergency, because these patients have a high risk of life-threatening complications including cardiac tamponade, acute aortic regurgitation, coronary flow obstruction, and occlusion of aortic branch vessels. The mortality rate is 1% to 2% per hour early after symptom o ...
... Type A AAD is a true surgical emergency, because these patients have a high risk of life-threatening complications including cardiac tamponade, acute aortic regurgitation, coronary flow obstruction, and occlusion of aortic branch vessels. The mortality rate is 1% to 2% per hour early after symptom o ...
ESTUDO ACT
... A Pragmatic Multicenter Randomized Trial to Evaluate the Efficacy of Acetylcysteine for the Prevention of Renal Outcomes in Patients Undergoing Coronary and Vascular Angiography The ACT Trial Investigators ...
... A Pragmatic Multicenter Randomized Trial to Evaluate the Efficacy of Acetylcysteine for the Prevention of Renal Outcomes in Patients Undergoing Coronary and Vascular Angiography The ACT Trial Investigators ...
RELATIONSHIP BETWEEN SERUM MAGNESIUM LEVEL AND ARRYTHMIAS FOLLOWING POST-
... differences. Wistbacka et al. reported an AF rate of 7% and AF episodes rate of 24%33. In another study, AF rate was 50% of the cases in which only 36% needed treatment34. 2) Many studies have reported AF as a part of supraventricular dysrythmias and did not report it separately. Precise meta-analyt ...
... differences. Wistbacka et al. reported an AF rate of 7% and AF episodes rate of 24%33. In another study, AF rate was 50% of the cases in which only 36% needed treatment34. 2) Many studies have reported AF as a part of supraventricular dysrythmias and did not report it separately. Precise meta-analyt ...
The Influence of Type 2 Diabetes Mellitus in Patients Undergoing
... Results: A total of 6,711 patients were available for our analysis (diabetic patients, 2,178; and nondiabetic patients, 4,533). The diabetic patients were significantly more likely to be women, to have more left ventricular hypertrophy, to have a history of cerebrovascular disease, hypertension, and ...
... Results: A total of 6,711 patients were available for our analysis (diabetic patients, 2,178; and nondiabetic patients, 4,533). The diabetic patients were significantly more likely to be women, to have more left ventricular hypertrophy, to have a history of cerebrovascular disease, hypertension, and ...
Renal-Artery Stenosis
... Angioplasty and Stenting • Recent trials – 1. comparing stenting plus medical therapy with medical therapy alone • preservation of renal function • no significant benefits with the addition of stenting – 2. Angioplasty and Stenting for Renal Artery Lesions (ASTRAL) • stent revascularization in addi ...
... Angioplasty and Stenting • Recent trials – 1. comparing stenting plus medical therapy with medical therapy alone • preservation of renal function • no significant benefits with the addition of stenting – 2. Angioplasty and Stenting for Renal Artery Lesions (ASTRAL) • stent revascularization in addi ...
Drug-eluting stent
A drug-eluting stent (DES) is a peripheral or coronary stent (a scaffold) placed into narrowed, diseased peripheral or coronary arteries that slowly releases a drug to block cell proliferation. This prevents fibrosis that, together with clots (thrombi), could otherwise block the stented artery, a process called restenosis. The stent is usually placed within the peripheral or coronary artery by an interventional cardiologist or interventional radiologist during an angioplasty procedure.Drug-eluting stents in current clinical use were approved by the FDA after clinical trials showed they were statistically superior to bare-metal stents for the treatment of native coronary artery narrowings, having lower rates of major adverse cardiac events (usually defined as a composite clinical endpoint of death + myocardial infarction + repeat intervention because of restenosis). The first drug-eluting stents to be approved in Europe and the U.S. were coated with paclitaxel or an mTOR inhibitor, such as sirolimus.